Senior biopharmaceutical expert with extensive experience in the development of biological products. Rod demonstrates proven expertise across diverse biopharmaceutical disciplines, including regulatory experience and authoring CMC sections for clinical trials and commercial registrations. Rod holds a PhD from Aston University, UK.
This high-level discussion focuses on how to translate great science into usable vaccines - on time and at scale. With voices across the value chain, the panel will address:
Ideal for: Executives, BD leaders, CDMOs, policy makers, and global health stakeholders.